U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 476

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh38:
Chr16:3818098-3858843
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Aug 24, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr16:3789651
GRCh38:
Chr16:3739650
CREBBPD1365G, D1403GRubinstein-Taybi syndrome due to CREBBP mutationsLikely benign
(Jan 19, 2023)
criteria provided, single submitter
3.
CREBBPL2159fs, L2197fsRubinstein-Taybi syndrome due to CREBBP mutationsPathogenicno assertion criteria provided
4.
GRCh37:
Chr16:3843509
GRCh38:
Chr16:3793508
CREBBPH365PRubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Jun 26, 2023)
criteria provided, single submitter
5.
GRCh37:
Chr16:3828011
GRCh38:
Chr16:3778010
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogeniccriteria provided, single submitter
6.
GRCh37:
Chr16:3786194
GRCh38:
Chr16:3736193
CREBBPK1486R, K1524RRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Oct 19, 2022)
no assertion criteria provided
7.
GRCh37:
Chr16:3807328
GRCh38:
Chr16:3757327
CREBBPT1182I, T1220IRubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1Likely benign
(Jun 21, 2023)
criteria provided, single submitter
8.
GRCh37:
Chr16:3843535
GRCh38:
Chr16:3793534
CREBBPQ356fsRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Apr 1, 2023)
criteria provided, single submitter
9.
GRCh37:
Chr16:3767420-3860782
CREBBP, TRAP1Rubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Mar 9, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr16:3778879
GRCh38:
Chr16:3728878
CREBBPQ2019*, Q2057*Rubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Apr 29, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr16:3820750
GRCh38:
Chr16:3770749
CREBBPP863S, P901SRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Feb 16, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr16:3801818
GRCh38:
Chr16:3751817
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Feb 2, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr16:3828768-3828775
GRCh38:
Chr16:3778767-3778774
CREBBPD585fs, D623fsRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Jan 23, 2023)
criteria provided, single submitter
14.
GRCh37:
Chr22:41547912
GRCh38:
Chr22:41151908
EP300, LOC126863158Q939*, Q965*Rubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Aug 4, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr16:3786197-3786198
GRCh38:
Chr16:3736196-3736197
CREBBPF1485fs, F1523fsRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Jan 25, 2023)
criteria provided, single submitter
16.
GRCh37:
Chr16:3786099
GRCh38:
Chr16:3736098
CREBBPL1556V, L1518VRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Mar 23, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr16:3900907
GRCh38:
Chr16:3850906
CREBBPA64fsRubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogeniccriteria provided, single submitter
18.
GRCh37:
Chr16:3807892-3807915
GRCh38:
Chr16:3757891-3757914
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogeniccriteria provided, single submitter
19.
GRCh37:
Chr16:3860704
GRCh38:
Chr16:3810703
CREBBPG292ERubinstein-Taybi syndrome due to CREBBP mutationsUncertain significancecriteria provided, single submitter
20.
GRCh37:
Chr16:3779365
GRCh38:
Chr16:3729364
CREBBPQ1857*, Q1895*Rubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Sep 2, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr16:3817808
GRCh38:
Chr16:3767807
CREBBPV1017L, V1055LRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Oct 19, 2020)
criteria provided, single submitter
22.
GRCh37:
Chr16:3843513
GRCh38:
Chr16:3793512
CREBBPA364PRubinstein-Taybi syndrome due to CREBBP mutationsLikely benign
(Jun 11, 2020)
criteria provided, single submitter
23.
GRCh37:
Chr16:3779042-3779043
GRCh38:
Chr16:3729041-3729042
CREBBPV1964fs, V2002fsRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Mar 31, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr16:3789608
GRCh38:
Chr16:3739607
CREBBPY1379*, Y1417*Rubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Feb 2, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr16:3801757
GRCh38:
Chr16:3751756
CREBBPT1212N, T1250NRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Feb 2, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr16:3830780
GRCh38:
Chr16:3780779
CREBBPW554C, W592CRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Oct 18, 2020)
criteria provided, single submitter
27.
GRCh37:
Chr16:3779806
GRCh38:
Chr16:3729805
CREBBPG1710C, G1748CRubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Oct 19, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr16:3790462-3790466
GRCh38:
Chr16:3740461-3740465
CREBBPE1318fs, E1356fsRubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Sep 9, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr16:3860728
GRCh38:
Chr16:3810727
CREBBPG284fsRubinstein-Taybi syndrome due to CREBBP mutationsPathogeniccriteria provided, single submitter
30.
GRCh37:
Chr16:3786111-3786115
GRCh38:
Chr16:3736110-3736114
CREBBPE1513fs, E1551fsRubinstein-Taybi syndrome due to CREBBP mutationsPathogeniccriteria provided, single submitter
31.
GRCh37:
Chr16:3778489
GRCh38:
Chr16:3728488
CREBBPP2149S, P2187SRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Sep 10, 2021)
criteria provided, single submitter
32.
GRCh37:
Chr16:3828693
GRCh38:
Chr16:3778692
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Sep 26, 2021)
criteria provided, single submitter
33.
GRCh37:
Chr16:3778491
GRCh38:
Chr16:3728490
CREBBPN2148I, N2186IRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Jun 24, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr16:3779244
GRCh38:
Chr16:3729243
CREBBPT1897I, T1935IRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Jun 11, 2020)
criteria provided, single submitter
35.
GRCh37:
Chr16:3786792
GRCh38:
Chr16:3736791
CREBBPRubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndromeConflicting interpretations of pathogenicity
(Oct 18, 2022)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr16:3794903
GRCh38:
Chr16:3744902
CREBBPS1287I, S1325IMenke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, See cases
Uncertain significance
(Aug 17, 2021)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr16:3795285
GRCh38:
Chr16:3745284
CREBBPP1265S, P1303SRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(May 22, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr16:3790551
GRCh38:
Chr16:3740550
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(May 22, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr16:3807934
GRCh38:
Chr16:3757933
CREBBPN1124S, N1162SMenke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, not specified
Uncertain significance
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr16:3781196
GRCh38:
Chr16:3731195
CREBBPC1685W, C1723WRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(May 4, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr16:3779473-3779493
GRCh38:
Chr16:3729472-3729492
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(May 4, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr16:3823778-3823779
GRCh38:
Chr16:3773777-3773778
CREBBPP775fs, P813fsRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Feb 1, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr16:3781863
GRCh38:
Chr16:3731862
CREBBPR1564S, R1602SRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Apr 8, 2021)
criteria provided, single submitter
44.
GRCh37:
Chr16:3788649
GRCh38:
Chr16:3738648
CREBBPD1397E, D1435ERubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Aug 1, 2021)
criteria provided, single submitter
45.
GRCh37:
Chr16:3779338
GRCh38:
Chr16:3729337
CREBBPQ1866*, Q1904*Rubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Aug 1, 2021)
criteria provided, single submitter
46.
GRCh37:
Chr16:3799632
GRCh38:
Chr16:3749631
CREBBPE1240Q, E1278QRubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Aug 1, 2021)
criteria provided, single submitter
47.
GRCh37:
Chr16:3828731
GRCh38:
Chr16:3778730
CREBBPD601fs, D639fsRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Apr 20, 2022)
criteria provided, single submitter
48.
CREBBPM1950fs, M1988fsRubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1Likely pathogenic
(Feb 16, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr16:3808972
GRCh38:
Chr16:3758971
CREBBPRubinstein-Taybi syndrome, Inborn genetic diseases, Rubinstein-Taybi syndrome due to CREBBP mutations
Likely benign
(Jun 2, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr16:3777932
GRCh38:
Chr16:3727931
CREBBPRubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome
Likely benign
(Jun 25, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr16:3817767
GRCh38:
Chr16:3767766
CREBBPRubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome
Likely benign
(Mar 2, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr16:3808066
GRCh38:
Chr16:3758065
CREBBPRubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome
Likely benign
(Aug 12, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr16:3828712
GRCh38:
Chr16:3778711
CREBBPA606P, A644PRubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Feb 27, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr22:41513550
GRCh38:
Chr22:41117546
EP300G152SInborn genetic diseases, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to CREBBP mutations,
Menke-Hennekam syndrome 2, Colorectal cancer, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency
Conflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr16:3781374
GRCh38:
Chr16:3731373
CREBBPR1626L, R1664LRubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Feb 1, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr16:3779254
GRCh38:
Chr16:3729253
CREBBPT1894A, T1932AMenke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome,
Rubinstein-Taybi syndrome due to CREBBP mutations
Conflicting interpretations of pathogenicity
(Jul 14, 2022)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr16:3779201-3779202
GRCh38:
Chr16:3729200-3729201
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Mar 12, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr16:3860701
GRCh38:
Chr16:3810700
CREBBPV293ERubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Jun 18, 2020)
criteria provided, single submitter
59.
GRCh37:
Chr16:3807848
GRCh38:
Chr16:3757847
CREBBPP1153T, P1191TRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significancecriteria provided, single submitter
60.
GRCh37:
Chr16:3786056
GRCh38:
Chr16:3736055
CREBBPA1532V, A1570Vnot specified, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1
Uncertain significance
(Jan 18, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr16:3794937
GRCh38:
Chr16:3744936
CREBBPK1276*, K1314*Rubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Dec 9, 2021)
criteria provided, single submitter
62.
GRCh37:
Chr16:3808001
GRCh38:
Chr16:3758000
CREBBPR1102fs, R1140fsRubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Jan 3, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr16:3808051
GRCh38:
Chr16:3758050
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Jan 3, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr16:3790520
GRCh38:
Chr16:3740519
CREBBPL1300W, L1338WRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Jan 3, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr16:3823912
GRCh38:
Chr16:3773911
CREBBPR730Q, R768Qnot provided, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1
Uncertain significance
(Apr 1, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr16:3817722
GRCh38:
Chr16:3767721
CREBBPK1045N, K1083NRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Aug 5, 2021)
criteria provided, single submitter
67.
GRCh37:
Chr16:3779586
GRCh38:
Chr16:3729585
CREBBPQ1783R, Q1821RRubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1Uncertain significance
(Nov 16, 2021)
criteria provided, single submitter
68.
GRCh37:
Chr16:3900384
GRCh38:
Chr16:3850383
CREBBPV238Mnot provided, Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations,
Menke-Hennekam syndrome 1
Benign/Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr16:3778440-3778445
GRCh38:
Chr16:3728439-3728444
CREBBPMenke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome,
not provided
Uncertain significance
(Nov 16, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr16:3778724
GRCh38:
Chr16:3728723
CREBBPY2070*, Y2108*Rubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Oct 18, 2021)
criteria provided, single submitter
71.
GRCh37:
Chr16:3820853
GRCh38:
Chr16:3770852
CREBBPM828I, M866IInborn genetic diseases, Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations,
Menke-Hennekam syndrome 1, not provided
Conflicting interpretations of pathogenicity
(Jul 27, 2022)
criteria provided, conflicting interpretations
72.
GRCh37:
Chr16:3831200-3831203
GRCh38:
Chr16:3781199-3781202
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Oct 5, 2021)
no assertion criteria provided
73.
GRCh37:
Chr16:3779041
GRCh38:
Chr16:3729040
CREBBPP1965S, P2003SRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Aug 19, 2021)
criteria provided, single submitter
74.
GRCh37:
Chr16:3817738
GRCh38:
Chr16:3767737
CREBBPS1040L, S1078LRubinstein-Taybi syndrome, not provided, Rubinstein-Taybi syndrome due to CREBBP mutations,
Menke-Hennekam syndrome 1
Uncertain significance
(Jul 20, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr16:3807346
GRCh38:
Chr16:3757345
CREBBPY1176C, Y1214CMenke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, not provided
Uncertain significance
(Feb 22, 2023)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr16:3831319
GRCh38:
Chr16:3781318
CREBBPRubinstein-Taybi syndrome, not provided, Rubinstein-Taybi syndrome due to CREBBP mutations,
Menke-Hennekam syndrome 1
Benign
(Oct 29, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr16:3790412
GRCh38:
Chr16:3740411
CREBBPG1336A, G1374Anot provided, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1
Uncertain significance
(Oct 31, 2021)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr22:41545747
GRCh38:
Chr22:41149743
EP300not provided, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to CREBBP mutations,
Menke-Hennekam syndrome 2, Colorectal cancer, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency
Benign/Likely benign
(Aug 6, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr16:3820605
GRCh38:
Chr16:3770604
CREBBPP911L, P949LRubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, not provided,
Rubinstein-Taybi syndrome
Benign/Likely benign
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr16:3779212
GRCh38:
Chr16:3729211
CREBBPP1908A, P1946ARubinstein-Taybi syndrome, not provided, Rubinstein-Taybi syndrome due to CREBBP mutations,
Menke-Hennekam syndrome 1, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Aug 5, 2022)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr16:3823776
GRCh38:
Chr16:3773775
CREBBPRubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, Inborn genetic diseases,
Rubinstein-Taybi syndrome, not provided
Likely benign
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr16:3778660
GRCh38:
Chr16:3728659
CREBBPQ2092*, Q2130*Rubinstein-Taybi syndrome due to CREBBP mutationsLikely pathogenic
(Feb 24, 2021)
criteria provided, single submitter
83.
GRCh37:
Chr16:3798049-3803276
GRCh38:
Chr16:3748048-3753275
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Mar 17, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr16:3820994
GRCh38:
Chr16:3770993
CREBBPMenke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome
Likely benign
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr16:3789718
GRCh38:
Chr16:3739717
CREBBPD1343N, D1381NRubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1
Uncertain significance
(Jul 22, 2021)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr16:3778209
GRCh38:
Chr16:3728208
CREBBPG2242E, G2280ERubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndromeUncertain significance
(Sep 18, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr16:3795299
GRCh38:
Chr16:3745298
CREBBPY1260C, Y1298CRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Jun 19, 2020)
criteria provided, single submitter
88.
GRCh37:
Chr16:3808854
GRCh38:
Chr16:3758853
CREBBPRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Jan 3, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr16:3781305
GRCh38:
Chr16:3731304
CREBBPS1649F, S1687FMenke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome
Likely pathogenic
(Aug 26, 2021)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr22:41513791
GRCh38:
Chr22:41117787
EP300G232ARubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,
Menke-Hennekam syndrome 2, Colorectal cancer
Conflicting interpretations of pathogenicity
(Aug 22, 2022)
criteria provided, conflicting interpretations
91.
GRCh37:
Chr16:3831254
GRCh38:
Chr16:3781253
CREBBPP505A, P543ARubinstein-Taybi syndrome due to CREBBP mutationsLikely benign
(May 6, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr16:3929849
GRCh38:
Chr16:3879848
CREBBPMenke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Tip-toe gait
Uncertain significance
(Sep 22, 2021)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr16:3900857
GRCh38:
Chr16:3850856
CREBBPS80CRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Feb 21, 2018)
criteria provided, single submitter
94.
GRCh37:
Chr16:3777864
GRCh38:
Chr16:3727863
CREBBPI2395T, I2357TMenke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations
Uncertain significance
(Sep 11, 2021)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr16:3779206
GRCh38:
Chr16:3729205
CREBBPP1910T, P1948TRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Jun 4, 2020)
criteria provided, single submitter
96.
GRCh37:
Chr16:3929870-3929871
GRCh38:
Chr16:3879869-3879870
CREBBPK16fsRubinstein-Taybi syndrome due to CREBBP mutationsPathogenic
(Jan 22, 2019)
criteria provided, single submitter
97.
GRCh37:
Chr16:3799628
GRCh38:
Chr16:3749627
CREBBPP1241R, P1279RRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Mar 19, 2020)
criteria provided, single submitter
98.
GRCh37:
Chr16:3817744
GRCh38:
Chr16:3767743
CREBBPS1038F, S1076FRubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Jul 10, 2019)
criteria provided, single submitter
99.
GRCh37:
Chr16:3929813-4387545
TFAP4, CREBBP, GLIS2, ADCY9, SRLRubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutationsUncertain significance
(Jul 3, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr16:3820597
GRCh38:
Chr16:3770596
CREBBPV914M, V952MRubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome,
Rubinstein-Taybi syndrome due to CREBBP mutations
Conflicting interpretations of pathogenicity
(Jul 12, 2022)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination